The Lung Cancer Initiative of North Carolina is proud to announce the recipients of the 2017-2018 Lung Cancer Research Fellows Program, designed to further the development of local lung cancer care and research across the state of North Carolina. The five grants totaling $125,000, are awarded to a fellow at each of five medical institutions across the state.
"I am truly thankful to the Lung Cancer Initiative of NC for this great opportunity. This project would provide hands-on experience of being a clinical investigator, opportunity to refine my skills of collaborating with basic and translational research scientists, and valuable experience of conducting clinical investigations with a focus on biomarker discovery and experimental therapeutics of lung cancer." - Mufti N. Ahmad, MBBS, Levine Cancer Institute
Emily Harrison, PhD (University of North Carolina at Chapel Hill)
Nanoparticle Delivery of Anti-Metastic miR-671 in Lung Squamous Carcinoma
Rachel Jug, MB BCh BAO & Coral X Giovacchini, MD (Duke University Medical Center)
PD-L1 Immunohistochemistry in NSCLC: Comparison of Cytology and Surgical Pathology
Mufti N. Ahmad, MBBS (Levine Cancer Insititute)
Exploration of Combined Tumor Mutational Burden Assessment and Peripheral Immune Profiling to Predict Clinical Outcomes to Immuno-Chemotherapy Agents in Non-Small Cell Lung Cancer (NSCLC)
Aparna Hegde, MBBS (Brody School of Medicine/ East Carolina University)
A Correlation of Circulating Micro-Particles, Soluble P-Selection and Anti-Annexin A2 Antibodies with Thrombosis and Their Prognostic Value in Lung Cancer Patients Receiving Immune Checkpoint Blockade Therapy
Laurie Steffen, PhD (Wake Forest Baptist Medical Center)
Identifying Symptom Burden and Unmet Supportive Care Needs in Lung Cancer Patients on Immunotherapy
Lung cancer takes more lives than breast, prostate and colon cancers combined, yet is greatly underfunded. The Research Fellows Program is designed to support young scientists in a way that will help them to develop pilot data for future larger grants. Since 2008, we have funded $1.1 million in lung cancer research.